Inflammatory response to fungal keratitis

Ocular Surface

Volumn 3, Issue 4, 2005, Pages S152-S153

  Mitchell, Bradley M ^a,b   Wilhelmus, Kirk R ^a  

^a CULLEN EYE INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Candida albicans; Fungal keratitis; Fusarium solani; Matrix metalloproteinases; MMP

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; GELATINASE A; GELATINASE B;

ARTICLE; CORNEA STROMA; IMMUNOSUPPRESSIVE TREATMENT; KERATOMYCOSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

EID: 84949116641     PISSN: 15420124     EISSN: 19375913     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. O'Day DM. Fungal keratitis, in Pepose JS, Holland GN, Wilhelmus KR (eds). Ocular infection and immunity. Mosby Year Book, St. Louis, MO, 1996, pp 1048-61
2. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 1980;90:38-47
3. Hube B, Naglik J. Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 2001;147:1997-2005
4. Wu TG, Wilhelmus KR, Mitchell BM. Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci 2003;44:210-6
5. Wu TG, Keasler VV, Mitchell BM, Wilhelmus KR. Immunosuppression affects the severity of experimental Fusarium solani keratitis. J Infect Dis 2004;190:192-8
6. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002;86:1211-5
7. Thomas PA. Fungal infections of the cornea. Eye 2003;17:852-62
8. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003;16:730-97
9. Ma DH-K, Chen J-K, Kim W-S, et al. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophthalmic Res 2001;33:353-62
10. Mohan R, Chintala SK, Jung JC, et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 2002;277:2065-72
11. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002;21:1-14
12. Wong TT, Sethi C, Daniels JT, et al. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol 2002;47:239-56
13. Miyajima S, Akaike T, Matsumoto K, et al. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Pathog 2001;31:271-81
14. Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci 2003;44:2020-5
15. Lee S, Zheng M, Kim B, Rouse BT. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 2002;110:1105-11
16. Yang YN, Bauer D, Wasmuth S, et al. Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res 2003;77:227-37